PRAME and metastatic melanoma: PRAME, a cancer testis antigen first isolated in tumor-reactive T cell clones from metastatic melanoma, is highly abundant and acts as a prognostic marker for several cancers including melanoma and ovarian adenocarcinoma (Haqq et al. 2005; Partheen et al. 2008).